Callan Family Office’s iShares MSCI EAFE Growth ETF EFG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.8M Sell
54,617
-5,227
-9% -$630K 0.13% 153
2026
Q1
$6.66M Buy
59,844
+2,824
+5% +$332K 0.15% 147
2025
Q4
$6.5M Buy
57,020
+15,109
+36% +$1.73M 0.14% 151
2025
Q3
$4.77M Buy
41,911
+91
+0.2% +$10.1K 0.15% 151
2025
Q2
$4.68M Sell
41,820
-3,271
-7% -$345K 0.15% 162
2025
Q1
$4.51M Sell
45,091
-2,015
-4% -$205K 0.34% 66
2024
Q4
$4.56M Sell
47,106
-490
-1% -$49.8K 0.29% 67
2024
Q3
$5.12M Buy
47,596
+650
+1% +$67.4K 0.86% 26
2024
Q2
$4.8M Sell
46,946
-320
-0.7% -$32.7K 0.92% 25
2024
Q1
$4.91M Buy
47,266
+175
+0.4% +$17.4K 1.15% 20
2023
Q4
$4.56M Buy
47,091
+2,179
+5% +$195K 1.13% 19
2023
Q3
$3.88M Sell
44,912
-219
-0.5% -$20.2K 1.03% 21
2023
Q2
$4.31M Sell
45,131
-100
-0.2% -$9.51K 1.14% 21
2023
Q1
$4.24M Buy
45,231
+3,118
+7% +$280K 1.03% 21
2022
Q4
$3.53M Buy
+42,113
New +$3.4M 1.14% 19

Other funds holding EFG

Callan Family Office's EFG Position: Q2 2026 in Review

Callan Family Office reduced its iShares MSCI EAFE Growth ETF (EFG) stake by 8.7% in Q2 2026, selling an estimated $630K and leaving 54,617 shares worth $6.8M. The position accounts for 0.13% of the portfolio, ranked #153.

Callan Family Office first reported a position in EFG in Q4 2022 and has held it in 15 quarters since. 1,062 funds tracked by Wall St. Rank hold EFG as of Q2 2026.

  • Callan Family Office held 54,617 shares of iShares MSCI EAFE Growth ETF worth $6.8M as of Q2 2026.
  • Callan Family Office sold 5,227 iShares MSCI EAFE Growth ETF shares in Q2 2026, an estimated $630K.
  • iShares MSCI EAFE Growth ETF made up 0.13% of Callan Family Office's portfolio in Q2 2026, its #153 holding.
  • Callan Family Office first reported a position in iShares MSCI EAFE Growth ETF in Q4 2022 and has held it in 15 quarters since.
  • 1,062 funds tracked by Wall St. Rank held iShares MSCI EAFE Growth ETF as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.